(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 21.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.89%.
Ceribell's revenue in 2025 is $77,419,000.On average, 2 Wall Street analysts forecast CBLL's revenue for 2025 to be $3,176,382,868, with the lowest CBLL revenue forecast at $3,173,999,710, and the highest CBLL revenue forecast at $3,178,766,026. On average, 2 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,060,901,096, with the lowest CBLL revenue forecast at $4,014,704,496, and the highest CBLL revenue forecast at $4,107,097,695.
In 2027, CBLL is forecast to generate $5,329,107,749 in revenue, with the lowest revenue forecast at $5,329,107,749 and the highest revenue forecast at $5,329,107,749.